Authored By: Sarah
11 Jul 2024

 Bone Cement Market Size to grow by USD 449.08 million between 2023-2027

According to a research report “ Bone Cement Market” by Product (Antibiotic-loaded bone cement, Non-antibiotic loaded bone cement) End-user (Hospitals, Clinics, Ambulatory surgery centers) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2027 published by Technavio, the market size is estimated to grow by USD 449.08 million, at a CAGR of  5.31% during the forecast period. Trauma is a significant health issue in North America, resulting in approximately 78,000 annual deaths for individuals under 45 years old in the US. This demographic represents a substantial loss of potential years of life, making trauma a leading contributor to disability and premature death for those under 65. Trauma can result in various injuries, including spinal cord injuries, joint injuries, and abdominal injuries. Subsequently, orthopedic surgeries, such as joint replacement and spinal cord fixation, are commonly employed to address trauma-related injuries and restore functionality.

Browse market data tables, figures, and in-depth TOC on “Bone Cement Market” by Product (Antibiotic-loaded bone cement, Non-antibiotic loaded bone cement) End-user (Hospitals, Clinics, Ambulatory surgery centers) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2027. Download Free Sample


By Product, the Antibiotic-loaded bone cement segment is projected to dominate the market size in 2024

The global bone cement market is significantly influenced by the healthcare sector, particularly hospitals. The primary reason being the easy accessibility of bone cement during orthopedic surgeries and joint fillings during prostheses or bone reconstructions. Hospitals' well-established infrastructure and the presence of skilled medical professionals enable a higher volume of interventional procedures, such as vertebroplasty. In this minimally invasive treatment for collapsed vertebrae and fractured bones, bone cement is injected through a needle into the affected area, solidifying within minutes to offer support and alleviate pain.

By End-user, Hospitals  segment is expected to hold the largest market size for the year 2024

The use of antibiotic-loaded bone cement in orthopedic procedures is a strategic approach to addressing local infections and osteomyelitis. PMMA, the primary component of bone cement, can effectively elute antibiotic molecules when incorporated into the cement. This property becomes more pronounced with increased cement porosity. The FDA-approved use of premixed bone cement containing 0.5g-1g of antibiotics per 40g of PMMA in second-stage reimplantation is a significant development in reducing infection-related complications during complex musculoskeletal surgeries such as joint arthroplasties and orthopedic procedures. The growing concern over infection issues in orthopedic surgery necessitates the increasing adoption of antibiotic-loaded bone cement to ensure successful surgical outcomes.

North America is forecasted to hold the largest market size by region in 2024

The North American region dominates the global bone cement market, with the United States leading as the primary revenue generator. This market dominance is attributed to the widespread utilization of minimally invasive procedures, such as joint reconstruction, fusion procedures, and fracture treatments, which are common in North America. The bone cement market expansion is driven by the increasing prevalence of orthopedic disorders and the subsequent surge in orthopedic-related surgeries. In response to the rising patient population, leading market players in the region are focusing on the development of highly biocompatible bone cement formulations. Additionally, the presence of numerous well-established companies and their headquarters in the US enables them to effectively target and serve this significant market.

The Bone Cement Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • aap Implantate AG
  • Alphatec Holdings Inc.
  • Colfax Corp.
  • Exactech Inc.
  • G21 Srl
  • Globus Medical Inc.
  • Heraeus Holding GmbH
  • Johnson and Johnson
  • Kyeron
  • Medacta International SA
  • Medtronic Plc
  • Merit Medical Systems Inc.
  • Olympus Corp.
  • Smith and Nephew plc
  • Stryker Corp.
  • Synimed Synergie Ingenierie Medicale SARL
  • Tecres Spa
  • Zimmer Biomet Holdings Inc.

For insights on company offerings- Request a sample report!

Research Analysis Overview

Title: Bone Cement Market: Orthopedic Procedures and Clinical Data Requirements Drive Growth The global bone cement market is witnessing significant growth due to the increasing number of orthopedic procedures. Synthetic (metal) implants, which require bone cement for fixation, are commonly used in surgeries for hip injuries, concussions, fractures, strains, sprains, and contusions. The market is driven by clinical data requirements set by regulatory authorities to ensure patient safety and efficacy. Start-ups and small firms are entering the market with innovative solutions, including advanced bone cements for minimally invasive surgeries and robotic assistance. However, high costs and stringent regulatory approvals pose challenges. The market is impacted by factors such as the global recession, which led to a decrease in hospital emergency room visits for non-critical conditions like pickleball injuries and skating incidents. Assumptions about the market size and growth are based on orthopedic conditions and advancements in technology. The bone cement market's future looks promising with the increasing prevalence of orthopedic conditions and technological advancements in the field. Despite challenges, the market is expected to grow at a steady pace in the coming years.

Market Research Overview

The Bone Cement Market has seen significant growth in recent years due to the increasing number of orthopedic procedures and the need for cost-effective alternatives to traditional implants. However, the use of bone cement in orthopedic surgery comes with its own set of challenges, including thermal necrosis, hypersensitivity reactions, and granuloma formation, leading to chronic inflammation and adverse tissue reactions. Inadequate cement fixation, excessive weight-bearing, and poor bone quality can result in implant loosening and tissue damage, leading to further complications such as embolism, nerve impingement, and cement leakage. Methacrylate monomers in bone cement can cause allergic reactions and infections, adding to product-related complications. Despite these challenges, the use of bone cement in open-TLIF procedures has shown positive impacts on in-hospitalization cost, surgical care, and patient satisfaction. Advanced bone cements are being developed to address these complications, with synthetic implants and bone graft substitutes gaining popularity. The regulatory environment and economic conditions, including the global recession, also impact the market. The buying behavior of providers, price sensitivity, and clinical data requirements are key factors influencing the market. The use of surgical robotics and minimally invasive surgeries is also expected to drive growth in the market. According to PubMed, orthopedic conditions such as shoulder injuries, knee injuries, hip injuries, and sports injuries continue to drive demand for bone cement. The market for bone cement is attractive for start-ups and small firms, but high costs and regulatory requirements remain challenges. The market for bone cement is expected to continue growing, driven by cost-saving goals, healthcare resource utilization, and the increasing prevalence of orthopedic conditions.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!